N Brock, J Pohl, B Schneider. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AnimalsAntineoplastic Agents/adverse effectsAntineoplastic Agents/therapeutic useCyclophosphamide/analogs & derivativesCyclophosphamide/pharmacokineticsCyclophosphamide/therapeutic useDose-Response Relationship, DrugDrug Evaluation, Preclinical/methodsIfosfamide/pharmacokineticsIfosfamide/therapeutic useMechlorethamine/pharmacokineticsMechlorethamine/therapeutic useMiceNeoplasms/drug therapyNitrogen Mustard Compounds/pharmacokineticsNitrogen Mustard Compounds/therapeutic useRats
Substances: See more » Antineoplastic AgentsNitrogen Mustard CompoundsMechlorethamineCyclophosphamidetrofosfamidenornitrogen mustardIfosfamide
Year: 1990 PMID: 2229130 DOI: 10.1007/bf01612986
Source DB: PubMed Journal: J Cancer Res Clin Oncol ISSN: 0171-5216 Impact factor: 4.553